Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
Recruiting · NCT03470467 · Observational (researchers observe without assigning treatment) · Lead sponsor: Ictal Group
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview
Who can take part
Inclusion criteria
- age \>= 18 years
- Posterior Reversible Encephalopathy Syndrome defined as:
- combination of consciousness impairment, seizure activity, headaches, visual abnormalities, nausea/vomiting, and focal neurological signs AND
- cerebral imaging abnormalities involving the white matter (brain CT scan hypodensities AND/OR Brain MRI hypoT1, hyper T2 FLAIR)
- intensive care unit admission
Exclusion criteria
- normal cerebral imaging
Where it is running
1 location listed.
- Intensive Care Unit - Versailles Hospital - Le Chesnay, France